OSLO: Photocure ASA announced that the European Patent Office (EPO) has granted patent EP 2983780 covering the commercial Cevira device in Europe until 2034. Cevira is a photodynamic drug-device combination product under development for non-surgical treatment of high-grade cervical dysplasia. In July 2019, Photocure announced that it had entered into a License Agreement providing Asieris…